The first case described a 67-year-old patient with antiphospholipid syndrome with multiple recurrent episodes of venous thromboembolism who, after therapy with the CD19 CAR-T, achieved seroconversion of anticardiolipin antibodies and withdrawal of anticoagulation without recurrence of thromboembolic events. This evidence concerns the gene CD19 and venous thromboembolism.